2 Large-Cap Stocks with Promising Prospects and 1 We Avoid

Large-cap stocks have the power to shape entire industries thanks to their size and widespread influence. With such vast footprints, however, finding new areas for growth is much harder than for smaller, more agile players.

This dynamic can trouble even the most skilled investors, but luckily for you, we started StockStory to help you navigate these trade-offs and uncover exceptional companies that break the mold. Keeping that in mind, here are two large-cap stocks that still have big upside potential and one whose momentum may slow.

Market Cap: $35.73 billion

Sporting most major chip manufacturers as its customers, Teradyne (NASDAQ:TER) is a US-based supplier of automated test equipment for semiconductors as well as other technologies and devices.

Why Are We Wary of TER?

1. Customers postponed purchases of its products and services this cycle as its revenue declined by 1.1% annually over the last five years

2. Operating profits fell over the last five years as its sales dropped and it struggled to adjust its fixed costs

3. Performance over the past five years shows each sale was less profitable as its earnings per share dropped by 6.6% annually, worse than its revenue

At $228.17 per share, Teradyne trades at 44.4x forward P/E. To fully understand why you should be careful with TER, check out our full research report (it’s free).

Market Cap: $76.37 billion

Founded in 2002 as a natural soda and juice company, Monster Beverage (NASDAQ:MNST) is a pioneer of the energy drink category, and its Monster Energy brand targets a young, active demographic.

Why Should You Buy MNST?

1. Healthy operating margin of 28% shows it’s a well-run company with efficient processes, and its profits increased over the last year as it scaled

2. Impressive free cash flow profitability enables the company to fund new investments or reward investors with share buybacks/dividends, and its improved cash conversion implies it’s becoming a less capital-intensive business

3. Stellar returns on capital showcase management’s ability to surface highly profitable business ventures

Monster is trading at $78.09 per share, or 35.5x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.

Market Cap: $189.7 billion

Pioneering minimally invasive surgery since its first da Vinci system was FDA-cleared in 2000, Intuitive Surgical (NASDAQ:ISRG) develops and manufactures robotic-assisted surgical systems that enable minimally invasive procedures across various medical specialties.

Why Do We Watch ISRG?

1. Products are seeing elevated demand as its system placement averaged 12.7% growth over the past two years

2. Estimated revenue growth of 14.3% for the next 12 months implies its momentum over the last two years will continue

3. Earnings growth has trumped its peers over the last five years as its EPS has compounded at 20.9% annually

Intuitive Surgical’s stock price of $533.90 implies a valuation ratio of 58.1x forward P/E. Is now a good time to buy? See for yourself in our comprehensive research report, it’s free.

Check out the high-quality names we’ve flagged in our Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.